ReviewThe Journal of eukaryotic microbiology2019

State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids.

Noelia Lander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.